Baxter To Pay Up To $330M To Buy ApaTech

Law360, New York (March 1, 2010, 1:03 PM EST) -- Pharmaceutical and medical device maker Baxter International Inc. has agreed to buy U.K.-based orthobiologic products company ApaTech for up to $330 million in a deal that will allow Baxter to enter the emerging bone fusion market.

The companies said Monday that Baxter will pay $240 million cash for the company. Illinois-based Baxter also may make additional payments of up to $90 million if certain sales milestones are achieved.

The deal allows Baxter to acquire ApaTech's Actifuse product, a silicate substituted calcium phosphate synthetic bone graft material...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.